nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—PAH—renal system—cervical cancer	0.0465	0.0903	CbGeAlD
Droxidopa—ADRB3—female reproductive system—cervical cancer	0.0291	0.0565	CbGeAlD
Droxidopa—DDC—renal system—cervical cancer	0.0265	0.0515	CbGeAlD
Droxidopa—ADRB3—female gonad—cervical cancer	0.0264	0.0514	CbGeAlD
Droxidopa—ADRA1D—epithelium—cervical cancer	0.022	0.0428	CbGeAlD
Droxidopa—DDC—female reproductive system—cervical cancer	0.0212	0.0412	CbGeAlD
Droxidopa—ADRA1B—renal system—cervical cancer	0.0209	0.0406	CbGeAlD
Droxidopa—SLC16A10—epithelium—cervical cancer	0.0196	0.0381	CbGeAlD
Droxidopa—SLC16A10—mammalian vulva—cervical cancer	0.017	0.033	CbGeAlD
Droxidopa—ADRA1D—female reproductive system—cervical cancer	0.0164	0.0318	CbGeAlD
Droxidopa—SLC16A10—female reproductive system—cervical cancer	0.0145	0.0283	CbGeAlD
Droxidopa—SLC16A10—vagina—cervical cancer	0.0132	0.0256	CbGeAlD
Droxidopa—SLC6A2—decidua—cervical cancer	0.0129	0.025	CbGeAlD
Droxidopa—ADRA1A—epithelium—cervical cancer	0.0126	0.0246	CbGeAlD
Droxidopa—DDC—lymph node—cervical cancer	0.0124	0.0241	CbGeAlD
Droxidopa—ADRA2C—uterine cervix—cervical cancer	0.0119	0.0232	CbGeAlD
Droxidopa—ADRB1—female reproductive system—cervical cancer	0.0119	0.0231	CbGeAlD
Droxidopa—ADRA1A—renal system—cervical cancer	0.0117	0.0228	CbGeAlD
Droxidopa—ADRA2C—decidua—cervical cancer	0.0114	0.0221	CbGeAlD
Droxidopa—ADRA2C—renal system—cervical cancer	0.0112	0.0217	CbGeAlD
Droxidopa—ADRA2C—endometrium—cervical cancer	0.0108	0.021	CbGeAlD
Droxidopa—ADRA2C—mammalian vulva—cervical cancer	0.0105	0.0203	CbGeAlD
Droxidopa—SLC6A2—female reproductive system—cervical cancer	0.0101	0.0197	CbGeAlD
Droxidopa—ADRA2C—uterus—cervical cancer	0.00996	0.0194	CbGeAlD
Droxidopa—ADRA2A—uterine cervix—cervical cancer	0.00953	0.0185	CbGeAlD
Droxidopa—ADRA2A—decidua—cervical cancer	0.00908	0.0177	CbGeAlD
Droxidopa—ADRA2A—endometrium—cervical cancer	0.00862	0.0168	CbGeAlD
Droxidopa—SLC16A10—lymph node—cervical cancer	0.00851	0.0165	CbGeAlD
Droxidopa—ADRA2A—mammalian vulva—cervical cancer	0.00834	0.0162	CbGeAlD
Droxidopa—ADRA2C—female gonad—cervical cancer	0.00815	0.0158	CbGeAlD
Droxidopa—ADRA2C—vagina—cervical cancer	0.0081	0.0157	CbGeAlD
Droxidopa—ADRA2A—uterus—cervical cancer	0.00795	0.0155	CbGeAlD
Droxidopa—ADRA2A—female reproductive system—cervical cancer	0.00714	0.0139	CbGeAlD
Droxidopa—ADRA2A—female gonad—cervical cancer	0.0065	0.0126	CbGeAlD
Droxidopa—ADRA2A—vagina—cervical cancer	0.00646	0.0126	CbGeAlD
Droxidopa—SLC6A2—lymph node—cervical cancer	0.00591	0.0115	CbGeAlD
Droxidopa—ADRA2C—lymph node—cervical cancer	0.00524	0.0102	CbGeAlD
Droxidopa—ADRA2A—lymph node—cervical cancer	0.00418	0.00813	CbGeAlD
Droxidopa—ADRA2A—Hemostasis—GP5—cervical cancer	0.00177	0.00365	CbGpPWpGaD
Droxidopa—PAH—Metabolism—CA9—cervical cancer	0.00176	0.00362	CbGpPWpGaD
Droxidopa—DDC—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00173	0.00356	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—TAAR6—cervical cancer	0.00173	0.00356	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—WNT2—cervical cancer	0.00171	0.00353	CbGpPWpGaD
Droxidopa—PAH—Disease—WNT5A—cervical cancer	0.00169	0.00347	CbGpPWpGaD
Droxidopa—DDC—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.00167	0.00343	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—TAAR6—cervical cancer	0.00162	0.00333	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—WNT2—cervical cancer	0.00156	0.00321	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—WNT2—cervical cancer	0.00155	0.00318	CbGpPWpGaD
Droxidopa—ADRA1B—AMPK Signaling—MTOR—cervical cancer	0.00154	0.00318	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—WNT2—cervical cancer	0.00153	0.00314	CbGpPWpGaD
Droxidopa—ADRA1B—LPA receptor mediated events—CASP3—cervical cancer	0.00151	0.00311	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—TAAR6—cervical cancer	0.0015	0.00309	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—WNT2—cervical cancer	0.00144	0.00297	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—WNT2—cervical cancer	0.00142	0.00293	CbGpPWpGaD
Droxidopa—ADRA1A—AMPK Signaling—MTOR—cervical cancer	0.00137	0.00282	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—WNT2—cervical cancer	0.00135	0.00278	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—AKAP13—cervical cancer	0.0013	0.00269	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—WNT5A—cervical cancer	0.0013	0.00267	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—WNT2—cervical cancer	0.00126	0.0026	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—TAAR6—cervical cancer	0.00124	0.00255	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—AKAP13—cervical cancer	0.00118	0.00244	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—WNT5A—cervical cancer	0.00118	0.00243	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—WNT2—cervical cancer	0.00117	0.00242	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—WNT5A—cervical cancer	0.00117	0.00241	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—WNT5A—cervical cancer	0.00116	0.00238	CbGpPWpGaD
Droxidopa—ADRA1B—LPA receptor mediated events—EGFR—cervical cancer	0.00115	0.00237	CbGpPWpGaD
Droxidopa—DDC—Metabolism—CA9—cervical cancer	0.00114	0.00234	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—TAAR6—cervical cancer	0.00113	0.00233	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—TAAR6—cervical cancer	0.00113	0.00232	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—TAAR6—cervical cancer	0.00112	0.0023	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—TAAR6—cervical cancer	0.00111	0.00228	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—WNT5A—cervical cancer	0.00109	0.00225	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—WNT5A—cervical cancer	0.00108	0.00222	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—TAAR6—cervical cancer	0.00105	0.00215	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—TAAR6—cervical cancer	0.00103	0.00212	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—TAAR6—cervical cancer	0.00103	0.00211	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—WNT5A—cervical cancer	0.00102	0.00211	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TAAR6—cervical cancer	0.00102	0.0021	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—TAAR6—cervical cancer	0.00102	0.00209	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—TAAR6—cervical cancer	0.001	0.00207	CbGpPWpGaD
Droxidopa—PAH—Disease—HES1—cervical cancer	0.00097	0.002	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—WNT5A—cervical cancer	0.000957	0.00197	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—TAAR6—cervical cancer	0.00095	0.00195	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—TAAR6—cervical cancer	0.000935	0.00192	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—TAAR6—cervical cancer	0.000914	0.00188	CbGpPWpGaD
Droxidopa—ADRA1B—AMPK Signaling—TP53—cervical cancer	0.000911	0.00187	CbGpPWpGaD
Droxidopa—DDC—Circadian rythm related genes—TP53—cervical cancer	0.000905	0.00186	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—WNT5A—cervical cancer	0.000889	0.00183	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—WNT2—cervical cancer	0.000879	0.00181	CbGpPWpGaD
Droxidopa—PAH—Disease—MTHFR—cervical cancer	0.000853	0.00176	CbGpPWpGaD
Droxidopa—PAH—Disease—TERT—cervical cancer	0.00085	0.00175	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—AKAP13—cervical cancer	0.00085	0.00175	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—TAAR6—cervical cancer	0.000849	0.00175	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—TAAR6—cervical cancer	0.00083	0.00171	CbGpPWpGaD
Droxidopa—ADRA1A—AMPK Signaling—TP53—cervical cancer	0.000809	0.00167	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—WNT2—cervical cancer	0.000801	0.00165	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—WNT2—cervical cancer	0.000797	0.00164	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—WNT2—cervical cancer	0.000794	0.00163	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—WNT2—cervical cancer	0.000783	0.00161	CbGpPWpGaD
Droxidopa—PAH—Disease—FGFR3—cervical cancer	0.00078	0.00161	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—AKAP13—cervical cancer	0.000774	0.00159	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—AKAP13—cervical cancer	0.000772	0.00159	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—TAAR6—cervical cancer	0.000771	0.00159	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—AKAP13—cervical cancer	0.000767	0.00158	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—AKAP13—cervical cancer	0.000757	0.00156	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—WNT2—cervical cancer	0.000741	0.00153	CbGpPWpGaD
Droxidopa—PAH—Disease—NOTCH1—cervical cancer	0.000733	0.00151	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—WNT2—cervical cancer	0.00073	0.0015	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—AKAP13—cervical cancer	0.000717	0.00148	CbGpPWpGaD
Droxidopa—PAH—Metabolism—MTHFR—cervical cancer	0.000714	0.00147	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—AKAP13—cervical cancer	0.000705	0.00145	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—AKAP13—cervical cancer	0.000703	0.00145	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—AKAP13—cervical cancer	0.0007	0.00144	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—AKAP13—cervical cancer	0.000697	0.00143	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AKAP13—cervical cancer	0.000688	0.00142	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—WNT5A—cervical cancer	0.000666	0.00137	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TAAR6—cervical cancer	0.000665	0.00137	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AKAP13—cervical cancer	0.000651	0.00134	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—WNT2—cervical cancer	0.000648	0.00133	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AKAP13—cervical cancer	0.000641	0.00132	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AKAP13—cervical cancer	0.000627	0.00129	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—WNT5A—cervical cancer	0.000607	0.00125	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TAAR6—cervical cancer	0.000606	0.00125	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—WNT5A—cervical cancer	0.000604	0.00124	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—WNT2—cervical cancer	0.000602	0.00124	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—WNT5A—cervical cancer	0.000601	0.00124	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TAAR6—cervical cancer	0.000601	0.00124	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—WNT5A—cervical cancer	0.000594	0.00122	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TAAR6—cervical cancer	0.000593	0.00122	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AKAP13—cervical cancer	0.000582	0.0012	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AKAP13—cervical cancer	0.000569	0.00117	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—WNT5A—cervical cancer	0.000562	0.00116	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TAAR6—cervical cancer	0.000561	0.00115	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—WNT5A—cervical cancer	0.000553	0.00114	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TAAR6—cervical cancer	0.000552	0.00114	CbGpPWpGaD
Droxidopa—PAH—Disease—MTOR—cervical cancer	0.000549	0.00113	CbGpPWpGaD
Droxidopa—PAH—Disease—CD4—cervical cancer	0.000548	0.00113	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AKAP13—cervical cancer	0.000529	0.00109	CbGpPWpGaD
Droxidopa—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000526	0.00108	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—WNT2—cervical cancer	0.000519	0.00107	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—CA9—cervical cancer	0.000495	0.00102	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—WNT5A—cervical cancer	0.000491	0.00101	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TAAR6—cervical cancer	0.00049	0.00101	CbGpPWpGaD
Droxidopa—PAH—Disease—CTNNB1—cervical cancer	0.000487	0.001	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—WNT2—cervical cancer	0.000473	0.000974	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—WNT2—cervical cancer	0.000469	0.000965	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—WNT2—cervical cancer	0.000463	0.000953	CbGpPWpGaD
Droxidopa—DDC—Metabolism—MTHFR—cervical cancer	0.000462	0.000951	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—WNT5A—cervical cancer	0.000456	0.000939	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AKAP13—cervical cancer	0.000456	0.000939	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TAAR6—cervical cancer	0.000456	0.000938	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—WNT2—cervical cancer	0.000438	0.000902	CbGpPWpGaD
Droxidopa—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000437	0.000899	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—WNT2—cervical cancer	0.000431	0.000887	CbGpPWpGaD
Droxidopa—PAH—Disease—STAT3—cervical cancer	0.000424	0.000873	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NOTCH2—cervical cancer	0.000424	0.000873	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AKAP13—cervical cancer	0.000415	0.000855	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AKAP13—cervical cancer	0.000412	0.000847	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AKAP13—cervical cancer	0.000406	0.000837	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—CA9—cervical cancer	0.000402	0.000827	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—WNT5A—cervical cancer	0.000394	0.00081	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000388	0.000799	CbGpPWpGaD
Droxidopa—PAH—Disease—EGFR—cervical cancer	0.000386	0.000794	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AKAP13—cervical cancer	0.000384	0.000791	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—WNT2—cervical cancer	0.000383	0.000788	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AKAP13—cervical cancer	0.000378	0.000779	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—WNT5A—cervical cancer	0.000359	0.000738	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—WNT2—cervical cancer	0.000356	0.000732	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—WNT5A—cervical cancer	0.000355	0.000731	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—WNT5A—cervical cancer	0.000351	0.000722	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—HES1—cervical cancer	0.000348	0.000716	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AKAP13—cervical cancer	0.000336	0.000692	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—WNT5A—cervical cancer	0.000332	0.000683	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—WNT5A—cervical cancer	0.000327	0.000672	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.000312	0.000643	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TERT—cervical cancer	0.000305	0.000627	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	0.00029	0.000597	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—FGFR3—cervical cancer	0.00028	0.000576	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NOTCH2—cervical cancer	0.000276	0.000569	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.00027	0.000555	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NOTCH1—cervical cancer	0.000262	0.00054	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NOTCH2—cervical cancer	0.000252	0.000518	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	0.000249	0.000513	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NOTCH2—cervical cancer	0.000246	0.000507	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—EGFR—cervical cancer	0.000234	0.000481	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NOTCH2—cervical cancer	0.000233	0.00048	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	0.000229	0.000472	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—HES1—cervical cancer	0.000226	0.000466	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—HES1—cervical cancer	0.000206	0.000425	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—HES1—cervical cancer	0.000204	0.000421	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	0.000204	0.000419	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—HES1—cervical cancer	0.000202	0.000416	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TP53—cervical cancer	0.000201	0.000414	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—MTHFR—cervical cancer	0.000201	0.000413	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TERT—cervical cancer	0.000198	0.000409	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MTOR—cervical cancer	0.000197	0.000405	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—HES1—cervical cancer	0.000191	0.000393	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000189	0.00039	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—HES1—cervical cancer	0.000188	0.000387	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TP53—cervical cancer	0.000188	0.000387	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—FGFR3—cervical cancer	0.000182	0.000375	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CASP3—cervical cancer	0.000181	0.000372	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TERT—cervical cancer	0.000181	0.000372	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TERT—cervical cancer	0.000179	0.000369	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TERT—cervical cancer	0.000177	0.000364	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CTNNB1—cervical cancer	0.000174	0.000359	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NOTCH1—cervical cancer	0.000171	0.000352	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TERT—cervical cancer	0.000167	0.000345	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—HES1—cervical cancer	0.000167	0.000344	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—FGFR3—cervical cancer	0.000166	0.000342	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TERT—cervical cancer	0.000165	0.000339	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	0.000164	0.000338	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—MTHFR—cervical cancer	0.000163	0.000336	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—FGFR3—cervical cancer	0.000162	0.000334	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NOTCH1—cervical cancer	0.000156	0.000321	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—HES1—cervical cancer	0.000155	0.000319	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	0.000154	0.000318	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	0.000154	0.000316	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TP53—cervical cancer	0.000153	0.000314	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NOTCH1—cervical cancer	0.000152	0.000314	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—EGFR—cervical cancer	0.000152	0.000314	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—STAT3—cervical cancer	0.000152	0.000313	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	0.000151	0.000311	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TERT—cervical cancer	0.000146	0.000301	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	0.000144	0.000297	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	0.000142	0.000292	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—EGFR—cervical cancer	0.000139	0.000286	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—EGFR—cervical cancer	0.000138	0.000284	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	0.000138	0.000283	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TERT—cervical cancer	0.000136	0.00028	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—EGFR—cervical cancer	0.000136	0.000279	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	0.000134	0.000276	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	0.000128	0.000264	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MTOR—cervical cancer	0.000128	0.000264	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	0.000126	0.00026	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	0.000126	0.000259	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	0.000125	0.000257	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CASP3—cervical cancer	0.000118	0.000243	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	0.000117	0.000241	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MTOR—cervical cancer	0.000117	0.00024	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TP53—cervical cancer	0.000116	0.000239	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MTOR—cervical cancer	0.000116	0.000238	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MTOR—cervical cancer	0.000114	0.000235	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CTNNB1—cervical cancer	0.000114	0.000234	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	0.000112	0.000231	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MTOR—cervical cancer	0.000108	0.000222	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CASP3—cervical cancer	0.000107	0.000221	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CASP3—cervical cancer	0.000106	0.000219	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MTOR—cervical cancer	0.000106	0.000219	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CASP3—cervical cancer	0.000105	0.000216	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	0.000104	0.000215	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CTNNB1—cervical cancer	0.000103	0.000213	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	0.000103	0.000211	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CTNNB1—cervical cancer	0.000101	0.000208	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CASP3—cervical cancer	9.94e-05	0.000205	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—STAT3—cervical cancer	9.9e-05	0.000204	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CASP3—cervical cancer	9.78e-05	0.000201	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	9.58e-05	0.000197	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MTOR—cervical cancer	9.44e-05	0.000194	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	9.43e-05	0.000194	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—STAT3—cervical cancer	9.02e-05	0.000186	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—EGFR—cervical cancer	9e-05	0.000185	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—STAT3—cervical cancer	8.94e-05	0.000184	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—STAT3—cervical cancer	8.82e-05	0.000182	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MTOR—cervical cancer	8.78e-05	0.000181	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CASP3—cervical cancer	8.69e-05	0.000179	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	8.37e-05	0.000172	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—STAT3—cervical cancer	8.35e-05	0.000172	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—STAT3—cervical cancer	8.22e-05	0.000169	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—EGFR—cervical cancer	8.2e-05	0.000169	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—EGFR—cervical cancer	8.12e-05	0.000167	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CASP3—cervical cancer	8.07e-05	0.000166	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—EGFR—cervical cancer	8.02e-05	0.000165	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	7.78e-05	0.00016	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—EGFR—cervical cancer	7.59e-05	0.000156	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TP53—cervical cancer	7.55e-05	0.000156	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—EGFR—cervical cancer	7.47e-05	0.000154	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—STAT3—cervical cancer	7.3e-05	0.00015	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TP53—cervical cancer	6.88e-05	0.000142	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TP53—cervical cancer	6.82e-05	0.00014	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—STAT3—cervical cancer	6.78e-05	0.00014	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TP53—cervical cancer	6.73e-05	0.000139	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—EGFR—cervical cancer	6.63e-05	0.000137	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TP53—cervical cancer	6.37e-05	0.000131	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TP53—cervical cancer	6.27e-05	0.000129	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—EGFR—cervical cancer	6.16e-05	0.000127	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TP53—cervical cancer	5.57e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TP53—cervical cancer	5.17e-05	0.000107	CbGpPWpGaD
